Best Online Consultation with Oncologist diagnosticians in Spain: TOP 11 doctors

Dr. Lana Bijelic is an oncological surgeon and specialist in peritoneal carcinomatosis who joined the Teknon Oncology Institute’s Carcinomatosis Surgical Group in 2019. She is certified by the American Board of Surgery and is a member of various scientific communities, including the American College of Surgeons and the Society of Surgical Oncology. She has held various research and clinical positions, and has been awarded numerous academic achievements.

Professor Felip is a medical doctor from the UAB who specializes in thoracic malignancy management and is responsible for thoracic cancer trials. She is a current member of various societies related to oncology and has authored many peer-reviewed articles and book chapters in the field. She is also an associate professor at the UAB and professor of medicine at the Universitat de Vic, and is involved in the training of medical students and residents.

This doctor has experience in endocrine treatment, collaborating on studies aimed at overcoming resistance to hormone therapy. They have also been involved in numerous phase 1, 2 and 3 studies in breast and melanoma, which have led to the approval of new drugs in new indications. Their main area of interest lies in immunotherapy for melanoma treatment and patient care. They have participated in trials that have led to the approval of cdk4/6 palbociclib and ribociclib inhibitors in the first line of metastatic breast cancer, and Pembrolizumab in the first line of metastatic melanoma, as well as the combination of Nivolumab and Ipilimumab. They are a member of the Breast Cancer Unit and Melanoma Unit at the Vall d'Hebron University Hospital and the Vall d'Hebron Institute of Oncology. This doctor is an experienced oncologist with expertise in breast cancer and melanoma treatments, including endocrine therapy, immunotherapy, and patient care. They have been involved in numerous clinical trials leading to the approval of new drugs in new indications.

Professor Bosch is a highly reputed leader in Chronic Lymphocytic Leukemia (CLL) and conducts clinical and basic research on CLL and other lymphoproliferative disorders, focusing on the molecular pathogenesis of CLL and new therapeutic approaches. He has published over 100 articles in prestigious journals and is a professor of haematology at the Vall d'Hebron University Hospital of Barcelona.

Doctor is a Medical Oncologist with expertise in angiogenesis, DNA repair mechanisms, and immunology. She has a degree in medicine from Complutense University of Madrid, a medical oncology MD from the same university, and a PhD from Univesidad Autonoma de Barcelona. She is a Co-Chair of the GEICO Group, Faculty member for the Gyn-Track in the European Society of Medical Oncology, Spanish Representative of GOG, Spanish representative in the Cervical Committee and Phase II Committee of the GCIG Group, and an active member of the American Society of Clinical Oncology, European Society of Medical Oncology, and the Spanish Association of Medical Oncology. She has authored over 100 publications and presentations.

Dr. Prat is a clinical scientist with expertise in breast cancer research, clinical trials, and gene expression. He has a MD degree from the University of Barcelona and completed a medical oncology fellowship at the Vall d'Hebron Institute of Oncology. He is Head of the Translational Genomics and Targeted Therapeutics in Solid Tumors Group at August Pi i Sunyer Biomedical Research Institute, President of the Board of Directors of SOLTI, and member of the Executive Committee of The Breast International Group. He has published 160 publications with 13.479 citations and is a Tenure-Track Professor of Barcelona University and Director of the Breast Pathology – Senology Master´s degree.